aspirinexacerb
respiratori
diseas
aerd
also
known
aspirininduc
asthma
aspirinintoler
asthma
aia
respiratori
disord
featur
nasal
obstruct
rhinorrhea
acut
asthma
attack
airway
constrict
induc
nonsteroid
antiinflammatori
drug
nsaid
aspirin
acetylsalicyl
acid
fig
indomethacin
fig
medic
sodium
succinateconjug
corticosteroid
eg
hydrocortison
sodium
succin
fig
food
addit
tartrazin
yellow
food
dye
fig
parahydroxybenzo
antisept
food
addit
known
paraben
fig
food
compon
sulfit
mint
salicyl
fig
hypersensit
nsaid
caus
substanc
known
aspirin
intoler
accord
asthma
guidelin
us
nation
heart
lung
blood
institut
adult
asthma
patient
pediatr
asthma
patient
aerd
japanes
asthma
guidelin
state
adult
asthma
patient
pediatr
asthma
patient
aerd
accord
guidelin
major
aerd
patient
adult
femal
affect
twice
often
male
factor
famili
histori
ethnic
geograph
region
influenc
suggest
genet
disord
relat
pathogenesi
aerd
nasal
polyp
dysosmia
frequent
aerd
patient
asthma
attack
trigger
aspirin
intoler
seriou
report
patient
receiv
emerg
treatment
asthma
aerd
sinc
aerd
report
patient
without
known
prior
exposur
trigger
compound
seem
underli
mechan
type
allergi
evid
show
treatment
chromoglyc
effect
aerd
suggest
mast
cell
may
play
pivot
role
condit
aspirin
intoler
also
observ
condit
call
aspirininduc
urticaria
aiu
urticaria
andor
angioedema
develop
h
exposur
nsaid
patient
chronic
urticaria
aerd
aiu
account
major
patient
aspirin
intoler
harada
et
al
report
aspirin
intoler
observ
patient
fooddepend
exerciseinduc
anaphylaxi
fdeia
condit
combin
food
allergi
respiratori
disord
mostli
relat
wheat
crustacean
fdeia
differ
aerd
sinc
mani
patient
teenag
boy
atop
diseas
suggest
fdeia
associ
type
allergi
patient
develop
asthma
attack
exercis
sever
hour
intak
caus
food
symptom
exercis
differ
aerd
fdeia
may
indic
type
allergi
atop
nonatop
import
may
suggest
nonatop
immun
activ
underli
atop
characterist
fdeia
accordingli
possibl
aspirin
intoler
separ
subsequ
bronchoconstrict
aerd
fdeia
shown
fig
enzym
phospholipas
releas
fatti
acid
cell
membran
phospholipid
arachidon
acid
one
fatti
acid
releas
metabol
variou
substanc
includ
prostaglandin
pg
leukotrien
lt
thromboxan
tx
thought
make
major
contribut
pathogenesi
inflammatori
diseas
arachidon
acid
metabolit
produc
cyclooxygenas
cox
also
call
prostaglandin
gh
synthas
pgh
ec
metabol
arachidon
acid
cyclooxygenas
activ
metabol
hydroperoxidas
activ
fig
metabolit
cox
known
contribut
inflamm
two
subtyp
cox
enzym
found
one
name
found
constitut
express
cell
name
found
induc
physiolog
experiment
inflammatori
stimuli
carcinogen
promot
thapsigargin
calcium
ionophor
transcript
protein
control
variou
transcript
factor
includ
nuclear
via
degrad
inhibitori
protein
specif
inhibitor
develop
avoid
side
effect
gastrointestin
ulcer
reveal
select
due
differ
tertiari
protein
structur
arachidon
acid
also
metabol
leukotrien
anoth
pathway
involv
convert
metabol
shown
fig
contain
cystein
residu
thu
call
cysteinyl
leukotrien
cyslt
cysteinyl
lt
origin
discov
slow
react
substanc
anaphylaxi
srsa
extract
lung
tissu
antigensensit
guinea
pig
shown
constrict
airway
smooth
muscl
anim
potent
slowli
continu
histamin
via
antihistamin
resist
mechan
urinari
concentr
cyslt
elev
aerd
patient
even
asthma
symptom
cyslt
inhibitor
inhibitor
cyslt
receptor
blocker
report
safe
effect
aerd
indic
involv
cyslt
mechan
underli
diseas
aspirin
antiinflammatori
analges
agent
market
sinc
oldest
chemic
synthes
drug
fig
found
mechan
action
aspirin
acid
nsaid
involv
inhibit
pg
product
molecular
mechan
aspirin
final
reveal
irrevers
acetyl
cox
inhibit
nsaid
indomethacin
fig
revers
inhibit
cox
almost
oral
dose
aspirin
mg
immedi
absorb
stomach
upper
small
intestin
maximum
serum
concentr
reach
within
min
metabol
salicyl
acid
fig
conjug
glucuron
sulfat
sodium
salt
one
metabolit
gentis
acid
fig
report
antiinflammatori
effect
interestingli
select
inhibitor
report
safe
aerd
patient
indic
pivot
involv
mechan
aerd
hypothes
suppress
prostaglandin
product
via
inhibit
cox
lead
accumul
excess
arachidon
acid
insid
outsid
cell
excess
arachidon
acid
metabol
cyslt
caus
asthma
attack
tri
develop
cellular
model
aerd
base
inhibit
pg
product
nsaid
previous
assess
effect
cyslt
product
mast
cell
line
deriv
rat
basophil
leukemia
choos
indomethacin
fig
nsaid
avoid
unexpect
protein
acetyl
use
aspirin
found
cyslt
product
increas
cell
pretreat
overnight
dinitrophenol
dnp
specif
immunoglobulin
e
ige
treat
dnpconjug
human
serum
albumin
creat
cellular
model
type
allergi
treatment
indomethacin
concentr
caus
dosedepend
chang
cyslt
product
almost
inhibit
product
product
significantli
increas
indomethacin
observ
regard
support
studi
planaguma
et
al
use
rat
kupffer
cell
ad
aspirin
mm
doubl
product
inhibit
product
approxim
tri
ad
arachidon
acid
dnphsa
cultur
medium
cell
cysteinyl
lt
product
significantli
increas
ad
arachidon
acid
combin
allerg
stimul
signific
chang
without
allerg
stimul
mention
aerd
thought
type
allerg
diseas
also
test
nonallerg
stimul
cell
calcium
ionophor
obtain
similar
result
observ
indic
induct
cyslt
product
indomethacin
may
requir
inflammatori
stimul
mast
cell
aerd
fundament
problem
arachidon
acid
metabol
lead
anoth
question
nt
patient
type
allergi
show
activ
mast
cell
increas
cyslt
product
aspirin
intoler
experi
describ
obtain
interest
result
indomethacin
slightli
significantli
increas
product
also
test
indomethacin
anoth
sourc
avoid
influenc
contamin
factor
result
observ
togo
et
al
report
aspirin
salicyl
increas
product
mast
cell
line
mous
bone
marrowderiv
mast
cell
suggest
mechan
involv
calcium
influx
follow
activ
cytosol
phospholipas
conclud
whether
observ
correspond
also
unclear
whether
effect
nsaid
relat
aerd
liu
et
al
studi
mice
knockout
microsom
pge
associ
metabol
fig
pretreat
dust
mite
extract
challeng
lysineaspirin
via
ventil
mark
increas
respiratori
tract
resist
elev
level
cyslt
histamin
indic
mast
cell
degranul
bronchoalveolar
lavag
fluid
ketorolac
select
inhibitor
celecoxib
select
inhibitor
fail
increas
respiratori
tract
resist
model
howev
receptor
agonist
significantli
inhibit
respons
receptor
knockout
mice
show
smaller
increas
knockout
mice
recent
observ
interleukin
il
type
helper
cytokin
releas
necrot
cell
alarmin
highli
express
lung
epithelium
knockout
mice
pretreat
mite
extract
nasal
polyp
aerd
patient
report
produc
mast
cell
increas
product
bone
marrowderiv
murin
mast
cell
murin
mast
cell
line
cell
receiv
ige
sensit
follow
antigen
treatment
also
report
receptor
express
mast
cell
atop
stimul
anoth
class
posit
memorytyp
cell
known
pathogen
cell
recent
propos
role
inflammatori
diseas
includ
asthma
though
relationship
pathogen
cell
aerd
unclear
cell
cytokin
could
activ
mast
cell
aerd
patient
observ
mpge
knockout
mice
respond
lysineaspirin
may
indic
inhibit
cytosol
pge
cpge
associ
fig
could
least
partli
involv
aerd
suggest
cpge
activ
could
effect
condit
nakatani
et
al
studi
effect
cpge
knockout
report
cpgesnul
mice
undergo
perinat
death
low
bodi
weight
hypoplast
skin
chang
alveolar
collaps
lung
day
postcoitum
contrast
heterozyg
knockout
mice
seem
normal
apart
cpge
protein
level
provid
inform
effect
nsaid
cpge
heterozyg
knockout
anim
previous
observ
auranofin
gold
compound
rheumatoid
arthriti
induc
increas
product
without
signific
induct
protein
within
h
inflammatori
treatment
rat
periton
macrophag
nitric
oxid
product
increas
also
report
auranofin
induc
cochaperon
heat
shock
protein
later
identifi
cpge
fig
reduct
pg
synthesi
via
play
import
role
aerd
auranofin
cpge
activ
could
effect
condit
find
cellular
model
suggest
mast
cell
may
requir
inflammatori
activ
overproduct
cyslt
cox
inhibit
class
cell
cytokin
may
involv
pathogenesi
aerd
activ
mast
cell
therefor
vitro
experi
may
abl
identifi
inflammatori
mediat
activ
mast
cell
pge
activ
result
clinic
implic
mechan
nsaid
act
cox
clear
explain
mani
inflammatori
phenomena
could
explain
effect
nsaid
inhibit
cox
activ
describ
caus
substanc
aerd
may
strongli
inhibit
pg
synthesi
previous
observ
ligand
two
wellknown
nuclear
receptor
peroxisom
proliferatoractiv
receptor
ppar
independ
reduc
cyslt
releas
stimul
mast
cell
line
may
suggest
possibl
role
unknown
target
nsaid
caus
substanc
aspirin
report
associ
phospholipas
enzym
liber
arachidon
acid
membran
phospholipid
fig
aspirin
nsaid
also
report
affect
variou
mitochondri
enzym
complex
includ
nadhubiquinon
oxidoreductas
complex
succin
dehydrogenas
complex
ii
cytochrom
bc
complex
complex
iii
cytochrom
c
oxidas
complex
iv
antimycin
specif
complex
iii
inhibitor
report
inhibit
histamin
releas
experiment
stimul
human
mast
cell
obtain
bronchoalveolar
lavag
antimycin
also
report
increas
reactiv
oxygen
speci
mitochondria
pollen
extracttr
human
alveolar
epitheli
cell
line
author
suggest
damag
mitochondri
respirationrel
protein
may
exacerb
inflamm
found
amino
acid
sequenc
acetyl
aspirin
cox
fslkg
also
primari
protein
structur
human
corona
viru
near
nonstructur
protein
nsp
domain
similar
amino
acid
align
murin
hepat
viru
could
find
nomenclatur
amino
acid
site
predict
whether
aspirin
nsaid
act
via
site
human
salicyl
acid
fig
secret
plant
respons
pathogen
induc
resist
virus
salicyl
receptor
plant
nonexpressor
pr
gene
homolog
mammal
protein
paralogu
tumor
necrosi
factortr
cell
demonstr
sodium
salicyl
mm
inhibit
degrad
via
inhibit
kinas
activ
recent
honjo
et
al
report
discoveri
gene
relat
thermal
nocicept
drosophila
larva
twenti
gene
human
ortholog
known
relat
pain
sensat
interest
pain
sensat
respiratori
tract
may
relat
cough
asthma
patient
known
enhanc
pain
nsaid
analges
possibl
aspirin
act
directli
indirectli
gene
product
enhanc
nocicept
sensat
inflamm
tradit
japanes
medicin
diseas
high
risk
occurr
futur
call
mibyou
think
aerd
patient
never
experienc
asthma
attack
could
consid
mibyou
patient
asthma
attack
associ
aerd
frequent
seriou
defin
whether
person
risk
aerd
asthma
occur
follow
intak
caus
substanc
could
determin
mechan
aerd
identifi
risk
asthma
mibyou
period
could
prevent
aerd
reduc
number
asthma
death
clinic
investig
aerd
need
addit
basic
studi
base
clinic
inform
could
also
help
clinician
understand
pathophysiolog
featur
diseas
